HEADER TRANSFERASE 24-OCT-12 2YOG TITLE PLASMODIUM FALCIPARUM THYMIDYLATE KINASE IN COMPLEX WITH A (THIO)UREA- TITLE 2 ALPHA-DEOXYTHYMIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYMIDYLATE KINASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.7.4.9; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: 3D7; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28 KEYWDS TRANSFERASE, MALARIA, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR C.HUAQING,J.CARRERO-LERIDA,A.P.G.SILVA,J.L.WHITTINGHAM,J.A.BRANNIGAN, AUTHOR 2 L.M.RUIZ-PEREZ,K.D.READ,K.S.WILSON,D.GONZALEZ-PACANOWSKA,I.H.GILBERT REVDAT 2 08-MAY-24 2YOG 1 COMPND REMARK HETNAM REVDAT 1 24-JUL-13 2YOG 0 JRNL AUTH H.CUI,J.CARRERO-LERIDA,A.P.G.SILVA,J.L.WHITTINGHAM, JRNL AUTH 2 J.A.BRANNIGAN,L.M.RUIZ-PEREZ,K.D.READ,K.S.WILSON, JRNL AUTH 3 D.GONZALEZ-PACANOWSKA,I.H.GILBERT JRNL TITL SYNTHESIS AND EVALUATION OF ALPHA-THYMIDINE ANALOGUES AS JRNL TITL 2 NOVEL ANTIMALARIALS. JRNL REF J.MED.CHEM. V. 55 10948 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 23240776 JRNL DOI 10.1021/JM301328H REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0088 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 61653 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3308 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4489 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.3360 REMARK 3 BIN FREE R VALUE SET COUNT : 267 REMARK 3 BIN FREE R VALUE : 0.3880 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3270 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 434 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.92000 REMARK 3 B22 (A**2) : 0.06000 REMARK 3 B33 (A**2) : -1.12000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.71000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.109 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.090 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.061 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.688 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3650 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4993 ; 1.443 ; 1.969 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 456 ; 5.142 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 182 ;35.772 ;25.385 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 686 ;13.588 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;21.592 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 536 ; 0.102 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2779 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2069 ; 1.343 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3408 ; 2.124 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1581 ; 3.024 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1551 ; 4.313 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 3650 ; 1.838 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 434 ; 5.871 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 3529 ; 4.664 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 2YOG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1290054565. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9330 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64980 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 23.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.80000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.0, 0.2 M LICL, 20% REMARK 280 PEG6000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.39500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 ASP A 3 REMARK 465 ALA A 142 REMARK 465 GLN A 143 REMARK 465 ASN A 144 REMARK 465 ARG A 145 REMARK 465 SER A 146 REMARK 465 ASP A 147 REMARK 465 TYR A 148 REMARK 465 GLY A 149 REMARK 465 GLU A 150 REMARK 465 GLU A 151 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 ARG B 18 REMARK 465 SER B 19 REMARK 465 GLY B 20 REMARK 465 GLN B 143 REMARK 465 ASN B 144 REMARK 465 ARG B 145 REMARK 465 SER B 146 REMARK 465 ASP B 147 REMARK 465 TYR B 148 REMARK 465 GLY B 149 REMARK 465 GLU B 150 REMARK 465 GLU B 151 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 30 CA CB CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN A 83 O HOH A 2113 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD2 ASP A 173 O HOH A 2042 2545 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 19 -7.08 -58.88 REMARK 500 ARG A 99 150.45 79.99 REMARK 500 TYR A 100 -149.26 -156.62 REMARK 500 TYR A 153 -1.67 65.22 REMARK 500 TRP A 209 45.90 -105.65 REMARK 500 ARG B 99 145.23 75.84 REMARK 500 TYR B 100 -150.74 -155.36 REMARK 500 TYR B 153 -14.99 74.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2055 DISTANCE = 5.90 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 74X A 211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 74X B 211 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WWF RELATED DB: PDB REMARK 900 PLASMODIUM FALCIPARUM THYMIDYLATE KINASE IN COMPLEX WITH TMP AND ADP REMARK 900 RELATED ID: 2WWG RELATED DB: PDB REMARK 900 PLASMODIUM FALCIPARUM THYMIDYLATE KINASE IN COMPLEX WITH DGMP AND REMARK 900 ADP REMARK 900 RELATED ID: 2WWH RELATED DB: PDB REMARK 900 PLASMODIUM FALCIPARUM THYMIDYLATE KINASE IN COMPLEX WITH AP5DT REMARK 900 RELATED ID: 2WWI RELATED DB: PDB REMARK 900 PLASMODIUM FALCIPARUM THYMIDYLATE KINASE IN COMPLEX WITH AZTMP AND REMARK 900 ADP REMARK 900 RELATED ID: 2YOF RELATED DB: PDB REMARK 900 PLASMODIUM FALCIPARUM THYMIDYLATE KINASE IN COMPLEX WITH A (THIO) REMARK 900 UREA-BETA-DEOXYTHYMIDINE INHIBITOR REMARK 900 RELATED ID: 2YOH RELATED DB: PDB REMARK 900 PLASMODIUM FALCIPARUM THYMIDYLATE KINASE IN COMPLEX WITH A UREA- REMARK 900 ALPHA-DEOXYTHYMIDINE INHIBITOR DBREF 2YOG A 1 210 UNP Q8I4S1 Q8I4S1_PLAF7 1 210 DBREF 2YOG B 1 210 UNP Q8I4S1 Q8I4S1_PLAF7 1 210 SEQRES 1 A 210 MET THR ASP ASP LYS LYS LYS GLY LYS PHE ILE VAL PHE SEQRES 2 A 210 GLU GLY LEU ASP ARG SER GLY LYS SER THR GLN SER LYS SEQRES 3 A 210 LEU LEU VAL GLU TYR LEU LYS ASN ASN ASN VAL GLU VAL SEQRES 4 A 210 LYS HIS LEU TYR PHE PRO ASN ARG GLU THR GLY ILE GLY SEQRES 5 A 210 GLN ILE ILE SER LYS TYR LEU LYS MET GLU ASN SER MET SEQRES 6 A 210 SER ASN GLU THR ILE HIS LEU LEU PHE SER ALA ASN ARG SEQRES 7 A 210 TRP GLU HIS MET ASN GLU ILE LYS SER LEU LEU LEU LYS SEQRES 8 A 210 GLY ILE TRP VAL VAL CYS ASP ARG TYR ALA TYR SER GLY SEQRES 9 A 210 VAL ALA TYR SER SER GLY ALA LEU ASN LEU ASN LYS THR SEQRES 10 A 210 TRP CYS MET ASN PRO ASP GLN GLY LEU ILE LYS PRO ASP SEQRES 11 A 210 VAL VAL PHE TYR LEU ASN VAL PRO PRO ASN TYR ALA GLN SEQRES 12 A 210 ASN ARG SER ASP TYR GLY GLU GLU ILE TYR GLU LYS VAL SEQRES 13 A 210 GLU THR GLN LYS LYS ILE TYR GLU THR TYR LYS HIS PHE SEQRES 14 A 210 ALA HIS GLU ASP TYR TRP ILE ASN ILE ASP ALA THR ARG SEQRES 15 A 210 LYS ILE GLU ASP ILE HIS ASN ASP ILE VAL LYS GLU VAL SEQRES 16 A 210 THR LYS ILE LYS VAL GLU PRO GLU GLU PHE ASN PHE LEU SEQRES 17 A 210 TRP SER SEQRES 1 B 210 MET THR ASP ASP LYS LYS LYS GLY LYS PHE ILE VAL PHE SEQRES 2 B 210 GLU GLY LEU ASP ARG SER GLY LYS SER THR GLN SER LYS SEQRES 3 B 210 LEU LEU VAL GLU TYR LEU LYS ASN ASN ASN VAL GLU VAL SEQRES 4 B 210 LYS HIS LEU TYR PHE PRO ASN ARG GLU THR GLY ILE GLY SEQRES 5 B 210 GLN ILE ILE SER LYS TYR LEU LYS MET GLU ASN SER MET SEQRES 6 B 210 SER ASN GLU THR ILE HIS LEU LEU PHE SER ALA ASN ARG SEQRES 7 B 210 TRP GLU HIS MET ASN GLU ILE LYS SER LEU LEU LEU LYS SEQRES 8 B 210 GLY ILE TRP VAL VAL CYS ASP ARG TYR ALA TYR SER GLY SEQRES 9 B 210 VAL ALA TYR SER SER GLY ALA LEU ASN LEU ASN LYS THR SEQRES 10 B 210 TRP CYS MET ASN PRO ASP GLN GLY LEU ILE LYS PRO ASP SEQRES 11 B 210 VAL VAL PHE TYR LEU ASN VAL PRO PRO ASN TYR ALA GLN SEQRES 12 B 210 ASN ARG SER ASP TYR GLY GLU GLU ILE TYR GLU LYS VAL SEQRES 13 B 210 GLU THR GLN LYS LYS ILE TYR GLU THR TYR LYS HIS PHE SEQRES 14 B 210 ALA HIS GLU ASP TYR TRP ILE ASN ILE ASP ALA THR ARG SEQRES 15 B 210 LYS ILE GLU ASP ILE HIS ASN ASP ILE VAL LYS GLU VAL SEQRES 16 B 210 THR LYS ILE LYS VAL GLU PRO GLU GLU PHE ASN PHE LEU SEQRES 17 B 210 TRP SER HET 74X A 211 31 HET 74X B 211 31 HETNAM 74X 1-[4-CHLORANYL-3-(TRIFLUOROMETHYL)PHENYL]-3-[[(2R,3S)- HETNAM 2 74X 5-[5-METHYL-2,4-BIS(OXIDANYLIDENE)PYRIMIDIN-1-YL]-3- HETNAM 3 74X OXIDANYL-OXOL AN-2-YL]METHYL]THIOUREA HETSYN 74X (THIO)UREA-ALPHA-DEOXYTHYMIDINE DERIVATIVE FORMUL 3 74X 2(C18 H18 CL F3 N4 O4 S) FORMUL 5 HOH *434(H2 O) HELIX 1 1 GLY A 20 ASN A 35 1 16 HELIX 2 2 THR A 49 LYS A 60 1 12 HELIX 3 3 SER A 66 GLU A 80 1 15 HELIX 4 4 HIS A 81 GLY A 92 1 12 HELIX 5 5 TYR A 100 LEU A 112 1 13 HELIX 6 6 ASN A 115 ASN A 121 1 7 HELIX 7 7 PRO A 122 GLN A 124 5 3 HELIX 8 8 LYS A 155 LYS A 167 1 13 HELIX 9 9 HIS A 168 ALA A 170 5 3 HELIX 10 10 LYS A 183 LYS A 197 1 15 HELIX 11 11 LYS B 21 ASN B 35 1 15 HELIX 12 12 THR B 49 LYS B 60 1 12 HELIX 13 13 SER B 66 GLU B 80 1 15 HELIX 14 14 HIS B 81 LYS B 91 1 11 HELIX 15 15 TYR B 100 ASN B 113 1 14 HELIX 16 16 ASN B 115 ASN B 121 1 7 HELIX 17 17 PRO B 122 GLN B 124 5 3 HELIX 18 18 LYS B 155 LYS B 167 1 13 HELIX 19 19 HIS B 168 ALA B 170 5 3 HELIX 20 20 LYS B 183 LYS B 197 1 15 SHEET 1 AA 5 VAL A 39 TYR A 43 0 SHEET 2 AA 5 TRP A 94 ASP A 98 1 O TRP A 94 N LYS A 40 SHEET 3 AA 5 PHE A 10 GLY A 15 1 O ILE A 11 N CYS A 97 SHEET 4 AA 5 VAL A 131 ASN A 136 1 O VAL A 131 N VAL A 12 SHEET 5 AA 5 TRP A 175 ASP A 179 1 O ILE A 176 N TYR A 134 SHEET 1 BA 5 VAL B 39 TYR B 43 0 SHEET 2 BA 5 TRP B 94 ASP B 98 1 O TRP B 94 N LYS B 40 SHEET 3 BA 5 PHE B 10 GLY B 15 1 O ILE B 11 N CYS B 97 SHEET 4 BA 5 VAL B 131 ASN B 136 1 O VAL B 131 N VAL B 12 SHEET 5 BA 5 TRP B 175 ASP B 179 1 O ILE B 176 N TYR B 134 CISPEP 1 PHE A 44 PRO A 45 0 -7.82 CISPEP 2 LEU A 208 TRP A 209 0 -1.42 CISPEP 3 LEU A 208 TRP A 209 0 -1.87 CISPEP 4 PHE B 44 PRO B 45 0 -3.50 CISPEP 5 LEU B 208 TRP B 209 0 3.31 SITE 1 AC1 15 ASP A 17 PHE A 44 PRO A 45 LEU A 59 SITE 2 AC1 15 LYS A 60 PHE A 74 ARG A 78 ARG A 99 SITE 3 AC1 15 SER A 103 GLY A 104 TYR A 107 HOH A2011 SITE 4 AC1 15 HOH A2102 HOH A2167 HOH A2220 SITE 1 AC2 16 PHE B 44 PRO B 45 ARG B 47 LEU B 59 SITE 2 AC2 16 LYS B 60 PHE B 74 ARG B 78 ARG B 99 SITE 3 AC2 16 SER B 103 GLY B 104 TYR B 107 HOH B2085 SITE 4 AC2 16 HOH B2112 HOH B2157 HOH B2213 HOH B2214 CRYST1 49.060 58.790 71.710 90.00 95.78 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020383 0.000000 0.002063 0.00000 SCALE2 0.000000 0.017010 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014016 0.00000